BT-11

$60M B round to propel Landos through Phase II IBD trials
BioCentury
Wed, 08/14/19 - 11:07 am
Landos Biopharma
clinical trials
ulcerative colitis
Crohn's Disease
BT-11
Landos Biopharma Initiates Ph I Trial of First-in-class Oral Treatment for IBD
Thu, 07/12/18 - 09:17 am
Landos Biopharma
ulcerative colitis
Chron's Disease
IBD
BT-11